A new study from Children's Hospital Los Angeles has revealed a surge of pediatric patients presenting with diabetic ketoacidosis throughout the COVID-19 pandemic.
Dr. James E Goldman and Dr. Osama Al-Dalahmah from the Department of Pathology and Cell Biology at Columbia University, provide an in-depth perspective on Huntington’s disease (HD) research.
The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), drives the epilepsy field ahead with new research benchmarks, Vicky Whittemore, PhD, Program Director reveals.
Dr Shireen Kassam MBBS, FRCPath, PhD, dipIBLM, Founder and Director of Plant-Based Health Professionals UK, explains a simple prescription for health as a remedy to chronic disease.
Dr Faye Riley, Senior Research Communications Officer at Diabetes UK, highlights how immunotherapy is raising hopes for the next big breakthrough in type 1 diabetes.
Dr Timothy Kwok, Professor at The Chinese University of Hong Kong, shares the development of the Electronic Cognitive Screen (EC-Screen) for population screening of dementia in older people.
Dr Eugene Durenard, CEO of Hyperbolic Holdings GmbH discusses promising emerging technologies in the field of early detection and prevention of major chronic diseases.
Ann G. Matthysse, Professor of Biology from The University of North Carolina at Chapel Hill, writes in detail about plague, the first pandemic disease including comment on bacteria.
